These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 6994499)

  • 1. Evaluation of nalbuphine hydrochloride.
    Miller RR
    Am J Hosp Pharm; 1980 Jul; 37(7):942-9. PubMed ID: 6994499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy.
    Errick JK; Heel RC
    Drugs; 1983 Sep; 26(3):191-211. PubMed ID: 6137354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug therapy reviews: evaluation of butorphanol tartrate.
    Ameer B; Salter FJ
    Am J Hosp Pharm; 1979 Dec; 36(12):1683-91. PubMed ID: 393109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the analgesic effect of intramuscular nalbuphine and morphine in patients with postoperative pain.
    Beaver WT; Feise GA
    J Pharmacol Exp Ther; 1978 Feb; 204(2):487-96. PubMed ID: 340643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butorphanol and nalbuphine: a pharmacologic comparison.
    Pallasch TJ; Gill CJ
    Oral Surg Oral Med Oral Pathol; 1985 Jan; 59(1):15-20. PubMed ID: 2983281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary effects of nalbuphine hydrochloride and butorphanol tartrate in sheep.
    O'Hair KC; Dodd KT; Phillips YY; Beattie RJ
    Lab Anim Sci; 1988 Feb; 38(1):58-61. PubMed ID: 3367623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new mixed agonist-antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats.
    Steinfels GF; Young GA; Khazan N
    NIDA Res Monogr; 1981 Feb; 34():138-44. PubMed ID: 6783923
    [No Abstract]   [Full Text] [Related]  

  • 9. Nalbuphine and pentazocine in an opioid-benzodiazepine sedative technique: a double-blind comparison.
    Graham JL; McCaughey W; Bell PF
    Ann R Coll Surg Engl; 1988 Jul; 70(4):200-4. PubMed ID: 3046465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experiences with nalbuphine].
    Pocta J; Malèk J
    Anaesthesiol Reanim; 1989; 14(6):367-70. PubMed ID: 2604830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic effect of intramuscular and oral nalbuphine in postoperative pain.
    Beaver WT; Feise GA; Robb D
    Clin Pharmacol Ther; 1981 Feb; 29(2):174-80. PubMed ID: 7006884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.
    Pircio AW; Gylys JA; Cavanagh RL; Buyniski JP; Bierwagen ME
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):231-57. PubMed ID: 60089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the analgesic effects of intravenous nalbuphine and pentazocine in patients with postoperative pain.
    Tammisto T; Tigerstedt I
    Acta Anaesthesiol Scand; 1977; 21(5):390-4. PubMed ID: 333852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nalbuphine hydrochloride: an alternative parenteral analgesic for patients with a compromised respiratory system.
    Rhodus NL; Fraziero RJ
    Compendium; 1988 Jun; 9(6):458-9, 462-4, 466. PubMed ID: 2977738
    [No Abstract]   [Full Text] [Related]  

  • 16. Ceiling effect for respiratory depression by nalbuphine.
    Romagnoli A; Keats AS
    Clin Pharmacol Ther; 1980 Apr; 27(4):478-85. PubMed ID: 7357806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers.
    Zacny JP; Conley K; Marks S
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1159-69. PubMed ID: 9067299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analgesia and adverse effects of nalbuphine (Nubain) in comparison with morphine following hysterectomy].
    Alon E; Krayer S; Hossli G
    Anaesthesist; 1984 Aug; 33(8):360-2. PubMed ID: 6385766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with nalbuphine, a new opioid analgesic, in acute myocardial infarction.
    Greenbaum RA; Kaye G; Mason PD
    J R Soc Med; 1987 Jul; 80(7):418-21. PubMed ID: 3309298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.